No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers
Amarin Corporation plc (NASDAQ:AMRN) announced that new REDUCE-IT data show that Vascepa/Vazkepa (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients…
Musk Had Twins With Neuralink Executive Shivon Zilis Through IVF: Report
The twins that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk fathered with Neuralink executive Shivon Zilis were conceived by in vitro fertilization (IVF), according to
Recap Of Friday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor…
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be…
Biomea Fusion Touts Additional Preclinical Data For Blood Cancer Candidate
Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of two posters at the 19th International Myeloma Society (IMS) Annual Meeting.
Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents
The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc’s (NASDAQ:NVAX) COVID-19 vaccine, Nuvaxovid…
Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the European Medicines Agency (EMA) for a booster dose of an…
Amarin’s New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes
New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes in patients with cardiovascular disease or diabetes with risk factors.
Novavax Obtains U.K. Regulatory Clearance For Nuvaxovid In Adolescents Aged 12-17 Years
The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted expanded conditional marketing authorization (CMA) for Novavax’s (NASDAQ: NVAX) lead asset Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caus